POTELIGEO had a median time to response of about 1 month in blood and 3 months in skin3,a-f

Time to response was measured based on a post hoc analysis; a finding from the post hoc analysis cannot be used to demonstrate differences between treatments and may not be applicable to all patients initiating POTELIGEO.

aResponse was defined by international response criteria for Mycosis Fungoides and Sézary Syndrome.5 bResponses in skin and blood must have persisted for ≥4 weeks to be confirmed and were evaluated every 4 weeks during treatment.1,4 cResponses in lymph nodes were evaluated at 4 weeks, then every 8 weeks for the first year, and every 16 weeks thereafter.3 dResponse in skin defined as ≥50% clearance of skin disease without new tumors, evaluated using the mSWAT.4 eResponse in blood defined as >50% decrease in high blood tumor burden (B2), assessed by central flow cytometry.4 fResponse in lymph nodes defined as cumulative reduction ≥50% of measurable disease of each abnormal lymph node and no new abnormal lymph nodes, evaluated by computed tomography (CT) scans.4 REFERENCES +